327 Nociplastic pain and early discontinuation of aromatase inhibitor therapy in breast cancer patients over age 65

OBJECTIVES/GOALS: Side effects are why up to 50% of women with hormone-positive breast cancer prematurely discontinue aromatase inhibitor (AI) therapy. Pain from altered nociception without clear tissue/nerve damage (nociplastic) is a hypothesized contributing factor to this. Our objective was to ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Joyce, Elizabeth, Kidwell, Kelley M., Henry, N. Lynn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Valued Approaches
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209056/
http://dx.doi.org/10.1017/cts.2022.184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209056/
http://dx.doi.org/10.1017/cts.2022.184

Ejemplares similares